Evidence map›Paper›PMID 34393073›Full record

ArticleDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2021

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients.

Pierluigi Toniutto, Alessio Aghemo, Paolo Grossi, Patrizia Burra, Permanent Transplant Commission of the Italian Association for the Study of the Liver

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 9 institutions in 1 country.

Pierluigi ToniuttoHepatology and liver transplantation unit, Department of Specialized Medicine, Azienda Ospedaliero Universitaria, Udine, Italy.
Alessio AghemoDivision of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
Paolo GrossiUnit of Infectious and Tropical Diseases, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Patrizia BurraMultivisceral Transplant Unit, Gastroenterology, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy. Electronic address: burra@unipd.it.
Permanent Transplant Commission of the Italian Association for the Study of the Liver
Agostino Gemelli University Polyclinic · ITCarlo Forlanini Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITPresidio Ospedaliero · ITUniversity of Bologna · ITUniversity of Insubria · ITUniversity of Padua · ITUniversity of Pisa · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Liver TransplantationCOVID-19 VaccinesHumansRNA, MessengerSARS-CoV-2Transplant RecipientsWaiting ListsCOVID-19 VaccinesRNA, Messenger

Identifiers

PMID34393073
PMCPMC8318693
OpenAlexW3191540578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.